SEC Form 3 · accession 0001185185-18-000529
Genprex, Inc. · GNPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan M. Confer
Officer — Chief Financial Officer
Period of report
Mar 28, 2018
Accepted (ET)
Mar 29, 2018 · 1:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595248
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Conmon Stock | holding | — | — | — | 73,526 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $0.01 | holding | — | — | — | — | Jul 25, 2022 | Common Stock | 116,973 | — | D |
| Stock option (right to buy)F1 | $0.96 | holding | — | — | — | — | Apr 11, 2026 | Common Stock | 161,396 | — | D |
| Stock option (right to buy)F1 | $5.29 | holding | — | — | — | — | Nov 3, 2026 | Common Stock | 86,894 | — | D |
Explanation of responses
- F1Fully vested